Eli Lilly plans to pay up to $7 billion to purchase Kelonia Therapeutics
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...
medications
Linda Yaccarino, who was formerly CEO of Musk X, is now leading the digital health firm eMed
Nearly a month after departing from her role as CEO of social media platform X, Linda Yaccarino is set to...
